Summaries of health policy coverage from major news organizations
FDA Approves Abbott, Roche HIV Tests
Abbott Laboratories on Friday announced that FDA has approved its test to detect and measure HIV viral loads, Reuters reports. According to Abbott, its RealTime HIV-1 test is intended in part to assess viral responses to treatment. It was developed for use on an Abbott system for DNA and RNA testing in molecular laboratories (Reuters, 5/11). In related news, Roche on Monday announced that FDA has approved its HIV diagnostic test, called Cobas AmpliPrep/Cobas TagMan HIV-1 Test. The test can be used to determine a patient's prognosis by measuring baseline HIV RNA levels or to monitor his or her treatment response (Dow Jones, 5/14).
This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.